Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production

Virology

Volumn 349, Issue 1, 2006, Pages 112-120

  Porcheray, Fabrice ^a   Samah, Boubekeur ^a   Léone, Cathie ^a   Dereuddre Bosquet, Nathalie ^a   Gras, Gabriel ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Activation; Chemokine; Cytokine; HIV; Inflammation; Macrophage

Indexed keywords

ANTIGEN; CD163 ANTIGEN; CD206 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; INFECTION SENSITIVITY; MACROPHAGE; MACROPHAGE ACTIVATION; PHENOTYPE; PRIORITY JOURNAL; TISSUE INJURY; TITRIMETRY; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MANNOSE-BINDING LECTINS; RECEPTORS, CCR5; RECEPTORS, CELL SURFACE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33646712321     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.02.031     Document Type: Article

References (70)

1. Akridge R.E., Oyafuso L.K., and Reed S.G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153 12 (1994) 5782-5789
2. Alfano M., and Poli G. The cytokine network in HIV infection. Curr. Mol. Med. 2 8 (2002) 677-689
3. Bailer R.T., Lee B., and Montaner L.J. IL-13 and TNF-alpha inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression. Eur. J. Immunol. 30 5 (2000) 1340-1349
4. Bergamini A., Bolacchi F., Faggioli E., Placido R., Vendetti S., Cappannoli L., Ventura L., Cerasari G., Uccella I., Andreoni M., and Rocchi G. HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages. Clin. Exp. Immunol. 112 1 (1998) 105-111
5. Biswas P., Poli G., Kinter A.L., Justement J.S., Stanley S.K., Maury W.J., Bressler P., Orenstein J.M., and Fauci A.S. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J. Exp. Med. 176 3 (1992) 739-750
6. Buechler C., Ritter M., Orso E., Langmann T., Klucken J., and Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukocyte Biol. 67 1 (2000) 97-103
7. Capobianchi M.R., Abbate I., Antonelli G., Turriziani O., Dolei A., and Dianzani F. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages. AIDS Res. Hum. Retrovir. 14 3 (1998) 233-240
8. Choe W., Volsky D.J., and Potash M.J. Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype. J. Virol. 75 22 (2001) 10738-10745
9. Connor R.I., and Ho D.D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68 7 (1994) 4400-4408
10. Cota M., Mengozzi M., Vicenzi E., Panina-Bordignon P., Sinigaglia F., Transidico P., Sozzani S., Mantovani A., and Poli G. Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine. Proc. Natl. Acad. Sci. U.S.A. 97 16 (2000) 9162-9167
11. Cowan H.B., Vick S., Conary J.T., and Shepherd V.L. Dexamethasone up-regulates mannose receptor activity by increasing mRNA levels. Arch. Biochem. Biophys. 296 1 (1992) 314-320
12. De Simone R., Ajmone-Cat M.A., and Minghetti L. Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol. Neurobiol. 29 2 (2004) 197-212
13. DeFife K.M., Jenney C.R., McNally A.K., Colton E., and Anderson J.M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 158 7 (1997) 3385-3390
14. Denis M., and Ghadirian E. Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1. AIDS Res. Hum. Retrovir. 10 7 (1994) 795-802
15. Dhawan S., Heredia A., Wahl L.M., Epstein J.S., Meltzer M.S., and Hewlett I.K. Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes. Pathobiology 63 2 (1995) 93-99
16. Emilie D., Maillot M.C., Nicolas J.F., Fior R., and Galanaud P. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat. J. Biol. Chem. 267 29 (1992) 20565-20570
17. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 4 (1998) 890-898
18. Fan S.X., Turpin J.A., Aronovitz J.R., and Meltzer M.S. Interferon-gamma protects primary monocytes against infection with human immunodeficiency virus type 1. J. Leukocyte Biol. 56 3 (1994) 362-368
19. Fantuzzi L., Belardelli F., and Gessani S. Monocyte/Macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis. J. Leukocyte Biol. 74 5 (2003) 719-725
20. Figdor C.G., Leemans J.M., Bont W.S., and de Vries J.E. Theory and practice of centrifugal elutriation (CE). Factors influencing the separation of human blood cells. Cell Biophys. 5 2 (1983) 105-118
21. Finnegan A., Roebuck K.A., Nakai B.E., Gu D.S., Rabbi M.F., Song S., and Landay A.L. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J. Immunol. 156 2 (1996) 841-851
22. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., and Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233 4760 (1986) 215-219
23. Gessani S., Borghi P., Fantuzzi L., Varano B., Conti L., Puddu P., and Belardelli F. Induction of cytokines by HIV-1 and its gp120 protein in human peripheral blood monocyte/macrophages and modulation of cytokine response during differentiation. J. Leukocyte Biol. 62 1 (1997) 49-53
24. Ghorpade A., Xia M.Q., Hyman B.T., Persidsky Y., Nukuna A., Bock P., Che M., Limoges J., Gendelman H.E., and Mackay C.R. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72 4 (1998) 3351-3361
25. Goerdt S., and Orfanos C.E. Other functions, other genes: alternative activation of antigen- presenting cells. Immunity 10 2 (1999) 137-142
26. Goerdt S., Politz O., Schledzewski K., Birk R., Gratchev A., Guillot P., Hakiy N., Klemke C.D., Dippel E., Kodelja V., and Orfanos C.E. Alternative versus classical activation of macrophages. Pathobiology 67 5-6 (1999) 222-226
27. Gordon S. The role of the macrophage in immune regulation. Res. Immunol. 149 7-8 (1998) 685-688
28. Grossman Z., Meier-Schellersheim M., Sousa A.E., Victorino R.M., and Paul W.E. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?. Nat. Med. 8 4 (2002) 319-323
29. Hammer S.M., Gillis J.M., Groopman J.E., and Rose R.M. In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. Proc. Natl. Acad. Sci. U.S.A. 83 22 (1986) 8734-8738
30. Han X., Becker K., Degen H.J., Jablonowski H., and Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur. J. Clin. Invest. 26 4 (1996) 286-292
31. Hartshorn K.L., Neumeyer D., Vogt M.W., Schooley R.T., and Hirsch M.S. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res. Hum. Retrovir. 3 2 (1987) 125-133
32. Hewson T.J., Logie J.J., Simmonds P., and Howie S.E. A CCR5-dependent novel mechanism for type 1 HIV gp120 induced loss of macrophage cell surface CD4. J. Immunol. 166 8 (2001) 4835-4842
33. Hogger P., Dreier J., Droste A., Buck F., and Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J. Immunol. 161 4 (1998) 1883-1890
34. Igarashi T., Brown C.R., Endo Y., Buckler-White A., Plishka R., Bischofberger N., Hirsch V., and Martin M.A. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. U.S.A. 98 2 (2001) 658-663
35. Karber G. Beitrag zur kollectiven behandlung pharmakologisher reheinversuche. Arch. Exp. Pathol. Pharmakol. (1931) 162
36. Karsten V., Gordon S., Kirn A., and Herbein G. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha. Immunology 88 1 (1996) 55-60
37. Kaul M., Garden G.A., and Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature (2001) 410
38. Kedzierska K., and Crowe S.M. Cytokines and HIV-1: interactions and clinical implications. Antiviral Chem. Chemother. 12 3 (2001) 133-150
39. Kedzierska K., Crowe S.M., Turville S., and Cunningham A.L. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev. Med. Virol. 13 1 (2003) 39-56
40. Kodelja V., Muller C., Politz O., Hakij N., Orfanos C.E., and Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 160 3 (1998) 1411-1418
41. Kornbluth R.S., Oh P.S., Munis J.R., Cleveland P.H., and Richman D.D. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169 3 (1989) 1137-1151
42. Kornbluth R.S., Oh P.S., Munis J.R., Cleveland P.H., and Richman D.D. The role of interferons in the control of HIV replication in macrophages. Clin. Immunol. Immunopathol. 54 2 (1990) 200-219
43. Koyanagi Y., O'Brien W.A., Zhao J.Q., Golde D.W., Gasson J.C., and Chen I.S. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241 4873 (1988) 1673-1675
44. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., and Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 409 6817 (2001) 198-201
45. Lane B.R., Markovitz D.M., Woodford N.L., Rochford R., Strieter R.M., and Coffey M.J. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 163 7 (1999) 3653-3661
46. Le Naour R., Raoul H., Mabondzo A., Henin Y., Bousseau A., and Dormont D. Treatment of human monocyte-derived macrophages with a TNF alpha synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replication. Res. Virol. 145 3-4 (1994) 199-207
47. Lee C., Tomkowicz B., Freedman B.D., and Collman R.G. HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways. J. Leukocyte Biol. 78 4 (2005) 1016-1023
48. Mabondzo A., Le Naour R., Raoul H., Clayette P., Lafuma C., Barre-Sinoussi F.C., Cayre Y., and Dormont D. In vitro infection of macrophages by HIV: correlation with cellular activation, synthesis of tumour necrosis factor alpha and proteolytic activity. Res. Virol. 142 2-3 (1991) 205-212
49. Montaner L.J., da Silva R.P., Sun J., Sutterwala S., Hollinshead M., Vaux D., and Gordon S. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J. Immunol. 162 8 (1999) 4606-4613
50. Naif H.M., Chang J., Ho-Shon M., Li S., and Cunningham A.L. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression. AIDS Res. Hum. Retrovir. 12 13 (1996) 1237-1245
51. Naif H.M., Li S., Alali M., Sloane A., Wu L., Kelly M., Lynch G., Lloyd A., and Cunningham A.L. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72 1 (1998) 830-836
52. Porcheray F., Viaud S., Rimaniol A.C., Leone C., Samah B., Dereuddre-Bosquet N., Dormont D., and Gras G. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142 (2005) 481-489
53. Schaer D.J., Boretti F.S., Schoedon G., and Schaffner A. Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br. J. Haematol. 119 1 (2002) 239-243
54. Schuitemaker H., Koot M., Kootstra N.A., Dercksen M.W., de Goede R.E., van Steenwijk R.P., Lange J.M., Schattenkerk J.K., Miedema F., and Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66 3 (1992) 1354-1360
55. Seljelid R., and Eskeland T. The biology of macrophages: I. General principles and properties. Eur. J. Haematol. 51 5 (1993) 267-275
56. Shepherd V.L., Cowan H.B., Abdolrasulnia R., and Vick S. Dexamethasone blocks the interferon-gamma-mediated downregulation of the macrophage mannose receptor. Arch. Biochem. Biophys. 312 2 (1994) 367-374
57. Silvestri G., and Feinberg M.B. Turnover of lymphocytes and conceptual paradigms in HIV infection. J. Clin. Invest. 112 6 (2003) 821-824
58. Singer I.I., Scott S., Kawka D.W., Chin J., Daugherty B.L., DeMartino J.A., DiSalvo J., Gould S.L., Lineberger J.E., Malkowitz L., Miller M.D., Mitnaul L., Siciliano S.J., Staruch M.J., Williams H.R., Zweerink H.J., and Springer M.S. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J. Virol. 75 8 (2001) 3779-3790
59. Staudinger R., Phogat S.K., Xiao X., Wang X., Dimitrov D.S., and Zolla-Pazner S. Evidence for CD4-enchanced signaling through the chemokine receptor CCR5. J. Biol. Chem. 278 12 (2003) 10389-10392
60. Stein M., Keshav S., Harris N., and Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176 1 (1992) 287-292
61. Sulahian T.H., Hogger P., Wahner A.E., Wardwell K., Goulding N.J., Sorg C., Droste A., Stehling M., Wallace P.K., Morganelli P.M., and Guyre P.M. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12 9 (2000) 1312-1321
62. Tuttle D.L., Harrison J.K., Anders C., Sleasman J.W., and Goodenow M.M. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J. Virol. 72 6 (1998) 4962-4969
63. Valentin A., Albert J., Svenson S.B., and Asjo B. Blood-derived macrophages produce IL-1, but not TNF-alpha, after infection with HIV-1 isolates from patients at different stages of disease. Cytokine 4 3 (1992) 185-191
64. Van den Heuvel M.M., Tensen C.P., van As J.H., Van den Berg T.K., Fluitsma D.M., Dijkstra C.D., Dopp E.A., Droste A., Van Gaalen F.A., Sorg C., Hogger P., and Beelen R.H. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J. Leukocyte Biol. 66 5 (1999) 858-866
65. Vyakarnam A., McKeating J., Meager A., and Beverley P.C. Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 4 1 (1990) 21-27
66. Wang J., Roderiquez G., Oravecz T., and Norcross M.A. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J. Virol. 72 9 (1998) 7642-7647
67. Weissman D., Poli G., and Fauci A.S. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res. Hum. Retrovir. 10 10 (1994) 1199-1206
68. Williams L., Jarai G., Smith A., and Finan P. IL-10 expression profiling in human monocytes. J. Leukocyte Biol. 72 4 (2002) 800-809
69. Wu L., Paxton W.A., Kassam N., Ruffing N., Rottman J.B., Sullivan N., Choe H., Sodroski J., Newman W., Koup R.A., and Mackay C.R. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185 9 (1997) 1681-1691
70. Yoo J., Chen H., Kraus T., Hirsch D., Polyak S., George I., and Sperber K. Altered cytokine production and accessory cell function after HIV-1 infection. J. Immunol. 157 3 (1996) 1313-1320